Fadar Oliver Otite1, Nicholas Liaw2, Priyank Khandelwal2, Amer M Malik2, Jose G Romano2, Tatjana Rundek2, Ralph L Sacco2, Seemant Chaturvedi2. 1. From the Departments of Neurology (F.O.O., N.L., P.K., A.M.M., J.G.R., T.R., R.L.S., S.C.) and Public Health Sciences (T.R., R.L.S.), University of Miami Miller School of Medicine, FL. oliverotite@gmail.com. 2. From the Departments of Neurology (F.O.O., N.L., P.K., A.M.M., J.G.R., T.R., R.L.S., S.C.) and Public Health Sciences (T.R., R.L.S.), University of Miami Miller School of Medicine, FL.
Abstract
OBJECTIVE: To evaluate trends in prevalence of cardiovascular risk factors (hypertension, diabetes, dyslipidemia, smoking, and drug abuse) and cardiovascular diseases (carotid stenosis, chronic renal failure [CRF], and coronary artery disease [CAD]) in acute ischemic stroke (AIS) in the United States. METHODS: We used the 2004-2014 National Inpatient Sample to compute weighted prevalence of each risk factor in hospitalized patients with AIS and used joinpoint regression to evaluate change in prevalence over time. RESULTS: Across the 2004-2014 period, 92.5% of patients with AIS had ≥1 risk factor. Overall age- and sex-adjusted prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse were 79%, 34%, 47%, 15%, and 2%, respectively, while those of carotid stenosis, CRF, and CAD were 13%, 12%, and 27%, respectively. Risk factor prevalence varied by age (hypertension: 44% in 18-39 years vs 82% in 60-79 years), race (diabetes: Hispanic 49% vs white 30%), and sex (drug abuse: men 3% vs women 1.4%). Using joinpoint regression, prevalence of hypertension increased annually by 1.4%, diabetes by 2%, dyslipidemia by 7%, smoking by 5%, and drug abuse by 7%. Prevalence of CRF, carotid stenosis, and CAD increased annually by 13%, 6%, and 1%, respectively. Proportion of patients with multiple risk factors also increased over time. CONCLUSIONS: Despite numerous guidelines and prevention initiatives, prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse in AIS increased across the 2004-2014 period. Proportion of patients with carotid stenosis, CRF, and multiple risk factors also increased. Enhanced risk factor modification strategies and implementation of evidence-based recommendations are needed for optimal stroke prevention.
OBJECTIVE: To evaluate trends in prevalence of cardiovascular risk factors (hypertension, diabetes, dyslipidemia, smoking, and drug abuse) and cardiovascular diseases (carotid stenosis, chronic renal failure [CRF], and coronary artery disease [CAD]) in acute ischemic stroke (AIS) in the United States. METHODS: We used the 2004-2014 National Inpatient Sample to compute weighted prevalence of each risk factor in hospitalized patients with AIS and used joinpoint regression to evaluate change in prevalence over time. RESULTS: Across the 2004-2014 period, 92.5% of patients with AIS had ≥1 risk factor. Overall age- and sex-adjusted prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse were 79%, 34%, 47%, 15%, and 2%, respectively, while those of carotid stenosis, CRF, and CAD were 13%, 12%, and 27%, respectively. Risk factor prevalence varied by age (hypertension: 44% in 18-39 years vs 82% in 60-79 years), race (diabetes: Hispanic 49% vs white 30%), and sex (drug abuse: men 3% vs women 1.4%). Using joinpoint regression, prevalence of hypertension increased annually by 1.4%, diabetes by 2%, dyslipidemia by 7%, smoking by 5%, and drug abuse by 7%. Prevalence of CRF, carotid stenosis, and CAD increased annually by 13%, 6%, and 1%, respectively. Proportion of patients with multiple risk factors also increased over time. CONCLUSIONS: Despite numerous guidelines and prevention initiatives, prevalence of hypertension, diabetes, dyslipidemia, smoking, and drug abuse in AIS increased across the 2004-2014 period. Proportion of patients with carotid stenosis, CRF, and multiple risk factors also increased. Enhanced risk factor modification strategies and implementation of evidence-based recommendations are needed for optimal stroke prevention.
Authors: Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin Journal: N Engl J Med Date: 2006-08-10 Impact factor: 91.245
Authors: Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol Journal: JAMA Date: 2003-08-20 Impact factor: 56.272
Authors: Maiken Tibæk; Christian Dehlendorff; Henrik S Jørgensen; Hysse B Forchhammer; Søren P Johnsen; Lars P Kammersgaard Journal: J Am Heart Assoc Date: 2016-05-11 Impact factor: 5.501
Authors: Elie S Al Kazzi; Brandyn Lau; Tianjing Li; Eric B Schneider; Martin A Makary; Susan Hutfless Journal: PLoS One Date: 2015-11-04 Impact factor: 3.240
Authors: Lian Gu; Jingyan Huang; Jinhong Li; Siyun Huang; Minhua Li; Lin Gong; Tongshun Li; Li Su Journal: Neuromolecular Med Date: 2018-04-30 Impact factor: 3.843
Authors: Shilpa Tyagi; Gerald Choon-Huat Koh; Luo Nan; Kelvin Bryan Tan; Helen Hoenig; David B Matchar; Joanne Yoong; Eric A Finkelstein; Kim En Lee; N Venketasubramanian; Edward Menon; Kin Ming Chan; Deidre Anne De Silva; Philip Yap; Boon Yeow Tan; Effie Chew; Sherry H Young; Yee Sien Ng; Tian Ming Tu; Yan Hoon Ang; Keng Hee Kong; Rajinder Singh; Reshma A Merchant; Hui Meng Chang; Tseng Tsai Yeo; Chou Ning; Angela Cheong; Yu Li Ng; Chuen Seng Tan Journal: BMC Health Serv Res Date: 2018-11-22 Impact factor: 2.655
Authors: Jodi D Edwards; Moira K Kapral; M Patrice Lindsay; Jiming Fang; Richard H Swartz Journal: J Am Heart Assoc Date: 2019-01-08 Impact factor: 5.501
Authors: Joseph M Dardick; David Flomenbaum; Daniel L Labovitz; Natalie Cheng; Ava L Liberman; Charles Esenwa Journal: Sci Rep Date: 2021-01-11 Impact factor: 4.379